Global hypo-methylation in a proportion of glioblastoma enriched for an astrocytic signature is associated with increased invasion and altered immune landscape

Author:

Boot James1ORCID,Rosser Gabriel1,Kancheva Dailya2,Vinel Claire1,Lim Yau Mun3ORCID,Pomella Nicola1,Zhang Xinyu1,Guglielmi Loredana1,Sheer Denise1,Barnes Michael4,Brandner Sebastian3,Nelander Sven5ORCID,Movahedi Kiavash2ORCID,Marino Silvia1ORCID

Affiliation:

1. Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University

2. Laboratory for Molecular and Cellular Therapy, Vrije Universiteit Brussel

3. Division of Neuropathology, The National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, and Department of Neurodegenerative Disease, Queen Square, Institute of Neurology, University College London

4. Centre for Translational Bioinformatics, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London

5. Department of Immunology Genetics and Pathology, Uppsala University

Abstract

We describe a subset of glioblastoma, the most prevalent malignant adult brain tumour, harbouring a bias towards hypomethylation at defined differentially methylated regions. This epigenetic signature correlates with an enrichment for an astrocytic gene signature, which together with the identification of enriched predicted binding sites of transcription factors known to cause demethylation and to be involved in astrocytic/glial lineage specification, point to a shared ontogeny between these glioblastomas and astroglial progenitors. At functional level, increased invasiveness, at least in part mediated by SRPX2, and macrophage infiltration characterise this subset of glioblastoma.

Funder

Brain Tumour Research Centre of Excellence QMUL

Cancer Research UK

Barts Charity

National Institute for Health Research UCLH BRC

Publisher

eLife Sciences Publications, Ltd

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Mechanistic Insights on Metformin and Arginine Implementation as Repurposed Drugs in Glioblastoma Treatment;International Journal of Molecular Sciences;2024-08-30

2. Unravelling the mosaic: Epigenetic diversity in glioblastoma;Molecular Oncology;2024-08-15

3. Epigenetic regulation of tumor-immune symbiosis in glioma;Trends in Molecular Medicine;2024-05

4. Role of Senescent Astrocytes in Health and Disease;International Journal of Molecular Sciences;2023-05-09

5. Epigenetics of Thymic Epithelial Tumors;Cancers;2023-01-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3